V Square Quantitative Management LLC Takes Position in Intuitive Surgical, Inc. $ISRG

V Square Quantitative Management LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, Holdings Channel reports. The institutional investor bought 4,443 shares of the medical equipment provider’s stock, valued at approximately $2,516,000.

A number of other hedge funds have also recently bought and sold shares of the stock. Holos Integrated Wealth LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $25,000. Newbridge Financial Services Group Inc. grew its stake in shares of Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 33 shares in the last quarter. Greykasell Wealth Strategies Inc. acquired a new position in Intuitive Surgical during the third quarter worth $27,000. Olistico Wealth LLC bought a new stake in Intuitive Surgical during the fourth quarter worth $28,000. Finally, Caitlin John LLC acquired a new stake in Intuitive Surgical in the third quarter valued at $30,000. 83.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ISRG. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. Raymond James Financial raised their target price on shares of Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a research note on Friday, January 23rd. Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 30th. BTIG Research restated a “buy” rating and issued a $616.00 price objective on shares of Intuitive Surgical in a research note on Friday, January 23rd. Finally, Barclays set a $712.00 target price on Intuitive Surgical and gave the stock an “overweight” rating in a research note on Monday, January 26th. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $607.00.

Insider Buying and Selling at Intuitive Surgical

In related news, VP Fredrik Widman sold 133 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the completion of the sale, the vice president directly owned 660 shares in the company, valued at approximately $326,673.60. The trade was a 16.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Mark Brosius sold 645 shares of the stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the sale, the senior vice president directly owned 1,613 shares in the company, valued at $782,321.13. This represents a 28.57% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 32,943 shares of company stock worth $17,279,568. 0.60% of the stock is currently owned by company insiders.

Intuitive Surgical Trading Up 2.1%

Intuitive Surgical stock opened at $462.28 on Thursday. The company has a market capitalization of $164.17 billion, a price-to-earnings ratio of 58.59, a PEG ratio of 3.49 and a beta of 1.68. Intuitive Surgical, Inc. has a 12 month low of $427.84 and a 12 month high of $603.88. The stock’s 50 day moving average is $483.27 and its 200-day moving average is $514.06.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.26. The firm had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same quarter last year, the business earned $2.21 EPS. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Stock advanced in the latest session, signaling short-term buying interest that reflects optimism about the company’s growth prospects. Intuitive Surgical, Inc. (ISRG) Advances But Underperforms Market: Key Facts
• Positive Sentiment: Coverage highlighting Intuitive’s AI push into surgical systems reinforces the long-term growth story (potential to improve outcomes, maintain da Vinci franchise leadership). This helps justify investor appetite despite near-term valuation questions. Intuitive Surgical’s AI Push Tests Valuation And Da Vinci Growth Story
• Positive Sentiment: Analyst/features pieces pointing to large new addressable markets (e.g., anti‑obesity procedures) and Intuitive’s strong balance-sheet position support a bullish multi‑year case. Intuitive Surgical Stock: The Dark Horse in the Massive Anti-Obesity Market
• Positive Sentiment: Coverage noting the company’s financial strength (low/no debt, strong margins) supports investor confidence in executing product and software roadmaps. This Healthcare Stock Has No Debt and a Near-Monopoly in Its Market
• Neutral Sentiment: Erste Group made very small trims to FY2026 and FY2027 EPS estimates (FY26: $8.21 from $8.22; FY27: $9.52 from $9.54). The moves are minor but signal cautious modeling around near-term execution/visibility.
• Negative Sentiment: Goldman Sachs cut its price target from $714 to $609 but kept a Buy rating — a material reduction in upside that could pressure sentiment despite the maintained positive view. Goldman Sachs Adjusts Price Target on Intuitive Surgical to $609 from $714; Maintains Buy
• Negative Sentiment: Evercore published a pessimistic forecast for ISRG, adding near-term downside risk from an influential sell‑side voice. Evercore Issues Pessimistic Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.